Ekta Aggarwal

Principal Account Manager

John Bell

CEO-Founder

Aaron Bell

Director, Google Research

Brendan Bulik-Sullivan

General Partner

Terri Burns

Partner

Brad Calder

VP and GM, Google Cloud Platform and Technical Infrastructure

Sumiran Das

Growth Equity Investor at Google Capital

Jamal Eason

Director of Product Management

Karim Faris

General Partner

Jacquelline Fuller

President

Raj Gajwani

Director, Orion Wifi @ Google Area 120

Margaret Georgiadis

President, Americas

Carletta Higginson

Director, Global Head of Music Publishing

Rahul Jain

Lead, Venture Capital and Startups - Google Cloud

Aftab Jutt

CEO

Sushrut Karanjkar

Director

David Krane

Mnaging Partner

Jess Kuizon

CEO

Skye Lee

Director of UX

Bibiana Leite

Director, Scaled Partnerships

Anthony Nakache

Managing Director, Google MENA

David Reshef

Venture Partner

Issi Rozen

Venture Partner

Philipp Schindler

Senior Vice President and Chief Business Officer

Aparna Sinha

Director, Product Management for Kubernetes and Anthos

Andrew R. Whalley

Director, Chrome Security

Andy Wheeler

General Partner

LightRoom Premium Mod APK Download Android

CEO

Co khi Nhan Do

CEO

Past deals in Predictive Analytics

Isomorphic Labs

Venture Round in 2025
Isomorphic Labs is a digital biology company that leverages artificial intelligence to revolutionize drug discovery. It develops innovative platforms to analyze and interpret complex biological data, aiding researchers in identifying potential drug candidates and predicting compound effects. The company partners with pharmaceutical firms to enhance drug development efficiency and accuracy, offering services such as data analysis, modeling, and simulation to support research and development efforts.

Layer Health

Series A in 2025
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.

Clear Labs

Series D in 2025
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Prudentia Sciences

Venture Round in 2025
Prudentia Sciences operates a platform that leverages artificial intelligence to assess and value drug development assets, thereby mitigating investment risks in the biopharmaceutical industry. Its platform facilitates a marketplace for drug assets, enabling investors and biopharma clients to expedite drug pipelines, optimize returns, and make informed decisions during portfolio strategy planning and dealmaking, ultimately aiming to enhance patient outcomes.

PGxAI

Grant in 2024
PGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data. Partnered with InterSystems, the largest patient data holder globally, and leveraging advanced tools like VectorSearch and GenAI, PGxAI accesses extensive real-world data to solve drug selection, dosage personalization, and identification of clinically relevant drug-drug interactions.

Climate X

Series A in 2024
Climate X is a global climate physical risk data analytics company that specializes in climate risk management services. The firm provides tools to project and predict the impacts of climate change and extreme weather events by integrating climate models with current real-world data. Through its physical modeling capabilities, Climate X enables businesses and governments to anticipate regulatory requirements and adapt to evolving climate-related challenges. Its clientele includes prominent financial institutions in sectors such as banking, real estate, and insurance, highlighting its relevance in a rapidly changing climate landscape.

Alethea

Series B in 2024
Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

W4A.io

Grant in 2024
Precursor to intelligent Hominid aka Silico Sapiens; Working on technologies of Web 4.0 or the fourth generation of web. Web 4.0 is symbiotic web, where Human and machines work in symbiosis. The idea being the symbiotic web is that once the metadata is organized humans and machines can interact in symbiosis with each other. Join the Web 4.0 community on w4a.io that is home to hundreds of thousands of developers, technologists, designers, users and enthusiasts.

Moonwalk Biosciences

Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company is creating a profiling and engineering technology platform that leverages advanced artificial intelligence to deliver an in-depth understanding of the epigenome in both health and disease. This innovative approach allows healthcare providers to explore new avenues for therapy discovery and facilitates the reprogramming of cells to restore their healthy state. By integrating AI-driven insights, Moonwalk Biosciences aims to transform the landscape of therapeutic development and improve patient outcomes.

Onward Assist

Grant in 2023
Onward Assist operates an advanced cancer prognostics platform aimed at enhancing treatment decisions for oncologists and ultimately improving patient outcomes. The platform employs machine learning and computer vision to provide automated diagnostic tools and treatment decision support specifically designed for histopathologists, radiologists, and oncologists. Its flagship product, PathAssist, integrates an AI layer with automated diagnostics in histopathology, a pathology workflow solution, and a cost-effective slide digitization hardware. By analyzing and predicting the behavior of cancer cells, Onward Assist facilitates deeper insights into tumors and surrounding tissues, thereby ensuring more accurate prognoses and effective treatment protocols.

Wright Research

Non Equity Assistance in 2023
Wright Research is a quantitative active investment firm that specializes in data-driven robo-investment management and advisory services. It caters to investors with varying risk profiles by employing purely quantitative investment management strategies. The firm utilizes extensive historical data, which includes fundamental, technical, macroeconomic, and alternative data, along with rigorous statistical testing to eliminate investor biases and backtesting errors. This approach provides clients with comprehensive analysis and tracking tools, enabling both individuals and businesses to engage in quantitative investing and enhance their returns. Wright Research is committed to helping investors achieve their financial objectives while effectively navigating investment risks.

Endimension Technology

Non Equity Assistance in 2023
Endimension specializes in artificial intelligence solutions for medical image analysis, focusing on the automatic detection of abnormalities and diseases from medical scans. By leveraging advanced AI algorithms, the company aims to enhance the accuracy of diagnostics, thereby reducing the risk of misdiagnosis among patients. Its platform incorporates predictive analytics to facilitate early-stage disease detection, ultimately improving the efficiency of healthcare organizations and optimizing patient turnaround times.

Layer Health

Seed Round in 2023
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.

Signos

Series B in 2023
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Aifficient.Tech

Pre Seed Round in 2023
AIfficient.Tech is a revolutionary platform designed to empower small and medium-sized enterprises (SMEs) through the power of artificial intelligence. With a focus on enhancing productivity, efficiency, and innovation, AIfficient.Tech offers a wide range of AI-driven services tailored to meet the unique needs of businesses across various industries. Our mission is to level the playing field for SMEs by providing them with AI solutions that were previously accessible only to industry giants. We aim to help businesses work smarter, not harder, by automating routine tasks and providing real-time data and predictive analytics for informed decision-making. What sets AIfficient.Tech apart is our extensive library of 1,500 predefined and trained Autonomous AI Agents, classified using ONET codes, that cater to a wide array of functions and industries. These roles act as intelligent virtual employees, known as Cognitive Autonomous Agents, that integrate seamlessly into existing workflows.

Causal Foundry

Grant in 2023
Causal Foundry is a personalization to solve the greatest challenges in healthcare and medicine.

Graft

Venture Round in 2023
Graft is a modern AI platform that allows data teams to create production-ready AI solutions with minimal effort. It eliminates the need for machine learning expertise, additional staffing, or infrastructure maintenance. The platform focuses on a data-centric approach, utilizing foundation models to enhance business outcomes. Additionally, Graft specializes in unstructured data analysis, harnessing artificial intelligence to process various types of data, including text, images, video, audio, and graphs. This capability enables clients to apply advanced analytical techniques effectively, ultimately driving improved results for their businesses.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

CropIn

Series D in 2022
Cropin, established in 2010, is a leader in the Agtech sector, renowned for developing the first global Intelligent Agriculture Cloud. Its platform empowers stakeholders in the agricultural ecosystem to utilize digitization and artificial intelligence, enhancing efficiency, productivity, and sustainability. Cropin has partnered with over 250 clients and has digitized 16 million acres of farmland, positively impacting the livelihoods of more than 7 million farmers. The company has amassed extensive farming data, covering 488 crops and 10,000 crop varieties across 56 countries, and has established a global 'Ag-intelligence' movement. Additionally, Cropin's farm management software integrates agriculture with information and communication technology, facilitating data-driven practices. This software supports various participants in the agricultural value chain, improving financial and operational outcomes while ensuring food quality and safety for consumers.

Upollo

Pre Seed Round in 2022
Upollo is a developer of a platform designed to enhance subscription business growth by predicting customer behaviors such as churn, conversion, and expansion. By analyzing extensive datasets, including over half a billion dollars in subscription revenue and billions of user events, Upollo provides insights that help subscription businesses globally. Customer success teams utilize the platform to proactively address potential churn and identify opportunities for expansion, while sales and marketing teams leverage its insights to target the right prospects and maximize revenue generation. Additionally, the platform offers real-time analytics to detect issues such as account sharing and the use of disposable contact information, facilitating more effective customer interactions and fostering informed decision-making.

BreezoMeter

Acquisition in 2022
BreezoMeter Ltd. is a company specializing in real-time air quality monitoring and health recommendations for consumers and businesses, operating primarily in the United States and Israel. Founded in 2014 and headquartered in Haifa, Israel, with an additional office in the U.S., BreezoMeter provides street-level air quality data and tailored health solutions for various demographics, including children and athletes. Its suite of APIs offers information on air pollution, pollen, and active fires, making it a preferred choice for companies like Siemens and Tata Motors. The company employs a unique multi-data layer approach that integrates data from governmental sensors, satellites, and weather patterns to achieve high accuracy in air quality reporting. With sophisticated modeling and artificial intelligence, BreezoMeter calculates air quality metrics at a resolution of 0.003 miles (5 meters/16 feet) on an hourly basis across more than 90 countries.

Arch Data, Inc (fka Meltano)

Seed Round in 2022
Meltano is an open-source DataOps platform that integrates various leading open-source tools for managing the data lifecycle. It incorporates the Singer standard for data integration, featuring a library of over 200 connectors, as well as tools like dbt for data transformation, Airflow for orchestration, and plans to include Superset for data visualization. Meltano aims to simplify the processes of configuration, deployment, and monitoring while allowing data teams to adopt practices such as version control and continuous integration/continuous deployment. The platform collaborates with a community of over 1,200 professionals from startups, global enterprises, and consultancies to advance data infrastructure. Thousands of active projects utilizing Meltano are presently in operation across various organizations, demonstrating its practical application and adaptability in the data management landscape.

Mirvie

Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

Graft

Pre Seed Round in 2022
Graft is a modern AI platform that allows data teams to create production-ready AI solutions with minimal effort. It eliminates the need for machine learning expertise, additional staffing, or infrastructure maintenance. The platform focuses on a data-centric approach, utilizing foundation models to enhance business outcomes. Additionally, Graft specializes in unstructured data analysis, harnessing artificial intelligence to process various types of data, including text, images, video, audio, and graphs. This capability enables clients to apply advanced analytical techniques effectively, ultimately driving improved results for their businesses.

Waltz Health

Series A in 2022
Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Viz

Series D in 2022
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Pecan

Series C in 2022
Pecan operates a predictive analytics platform that empowers businesses to forecast critical outcomes effectively. It utilizes a low-code interface that simplifies the predictive modeling process, allowing companies to generate accurate predictions without needing in-house data scientists or engineers. Pecan automates data preparation and feature engineering, enabling users, particularly SQL-trained business intelligence analysts, to create tailored predictive models quickly. The platform supports various industries, including fintech, insurance, retail, and consumer services, by providing pre-built models and templates that align with specific business objectives. This capability allows organizations to enhance customer lifetime value, retention, conversion rates, and demand forecasting. Pecan's solutions have a significant financial impact, influencing billions of dollars in revenue across various sectors.

InstaDeep

Series B in 2022
InstaDeep Ltd is a company that specializes in developing artificial intelligence-based decision-making systems for the enterprise sector. Founded in 2014 and headquartered in London, the company also has offices in Paris, Tunis, Nairobi, and Lagos. InstaDeep's platform is designed to enhance talent retention and training while providing a range of AI programs. These include optimized pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics. By utilizing these technologies, InstaDeep enables businesses to improve efficiencies in manufacturing, logistics, mobility, and energy, ultimately leading to increased return on investments.

Signos

Series A in 2021
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Snorkel AI

Series C in 2021
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Arch Data, Inc (fka Meltano)

Seed Round in 2021
Meltano is an open-source DataOps platform that integrates various leading open-source tools for managing the data lifecycle. It incorporates the Singer standard for data integration, featuring a library of over 200 connectors, as well as tools like dbt for data transformation, Airflow for orchestration, and plans to include Superset for data visualization. Meltano aims to simplify the processes of configuration, deployment, and monitoring while allowing data teams to adopt practices such as version control and continuous integration/continuous deployment. The platform collaborates with a community of over 1,200 professionals from startups, global enterprises, and consultancies to advance data infrastructure. Thousands of active projects utilizing Meltano are presently in operation across various organizations, demonstrating its practical application and adaptability in the data management landscape.

Clear Labs

Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

AWB BioTech

Series B in 2021
AWB BioTech uses data from preclinical and clinical studies to guide a drug’s effect on patients.

Saildrone

Grant in 2021
Saildrone, Inc. specializes in the design and manufacture of wind and solar-powered autonomous surface vehicles, known as Saildrones, which facilitate cost-effective ocean data collection at scale. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, fish stock analysis, and environmental monitoring. Saildrone's vehicles have traveled over 500,000 nautical miles and spent more than 13,000 days at sea, generating high-resolution datasets that provide critical insights for climate science, maritime security, and ecological management. By utilizing real-time data transmission via satellite, Saildrone enables clients to monitor and mitigate potential ecological disasters, contributing to better understanding and management of global environmental challenges.

Snorkel AI

Series B in 2021
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Predictiva

Grant in 2021
Predictiva is a company that provides an artificial intelligence platform designed to enhance financial trading and investment management using advanced Deep Reinforcement Learning algorithms. It offers solutions that cater to various financial assets, focusing on optimizing decision-making in complex financial markets. By leveraging cutting-edge AI technology, Predictiva aims to deliver predictable profits while minimizing risks, enabling users to engage in a more accurate, data-driven approach to trading. The platform is accessible to users without a background in AI or data science, utilizing autonomous machine learning algorithms to simplify the trading process and enhance financial intelligence for traders and investment managers.

Tempus

Series G in 2020
Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Tempus

Debt Financing in 2020
Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Olive

Venture Round in 2020
Olive deploys the AI workforce built specifically for healthcare, delivering hospitals and health systems increased revenue, reduced costs, and increased capacity. Olive automates repetitive, high-volume tasks and workflows, monitoring their performance, identifying improvements, and finding opportunities for new work. Olive gives power back to providers through her ever-growing, unparalleled intelligence made up of shared memories, collective wisdom, and global awareness, learning like a network so hospitals never have to solve the same problem twice. Olive was founded in 2012 and is headquartered in Columbus, Ohio.

Arkangel AI

Grant in 2020
Arkangel AI is a healthcare-focused technology company that provides a no-code artificial intelligence platform designed to help organizations develop, deploy, and manage machine learning algorithms at scale. Its platform enables the efficient detection of preventable diseases, producing results that are faster, scalable, accurate, and cost-effective. By facilitating the identification of health issues and their stages, Arkangel AI aims to promote equitable health conditions globally, empowering users to lead healthier lives free from preventable diseases.

Snorkel AI

Series A in 2020
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Snorkel AI

Seed Round in 2020
Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

PatientPing

Series C in 2020
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Clear Labs

Venture Round in 2020
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Owkin

Series A in 2020
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

AppSheet

Acquisition in 2020
AppSheet is a no-code platform that empowers business users to create powerful applications without the need for programming knowledge. Founded in 2014 and based in Seattle, WA, it allows users to connect with various data sources, including spreadsheets, relational databases, and cloud services. The platform facilitates the rapid development of customizable applications that can incorporate features such as offline access, workflow automation, and machine learning capabilities. These applications are designed to function across multiple platforms, including web, iOS, Android, and messaging services. AppSheet's focus on user-friendly app creation enables organizations to leverage their data effectively while adhering to IT governance and security standards.

CyberGRX

Series D in 2019
CyberGRX is a cybersecurity company based in Denver, Colorado, that specializes in third-party cyber risk management. The company offers a comprehensive platform designed to help organizations identify, assess, mitigate, and monitor their cyber risk exposure across their entire partner ecosystem. By leveraging automation and advanced analytics, CyberGRX enables enterprises to effectively manage and monitor risks associated with their vendors, partners, and customers. The platform provides a cost-effective and scalable solution, allowing organizations to gain complete visibility into their risk portfolio while facilitating real-time decision-making and predictive capabilities.

Viz

Series B in 2019
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Copper

Series C in 2019
Copper, Inc. is a provider of web-based customer relationship management (CRM) software specifically designed for Google applications, integrating seamlessly with G Suite. Founded in 2011 and headquartered in San Francisco, the company offers a platform that captures data automatically, enabling real-time tracking of sales opportunities and deals. Users can customize their CRM experience with features such as sales forecasting reports, custom fields, and pipeline filters. The software allows for mobile management of sales pipelines, call logging, automated task reminders, and push notifications for new records. Copper serves various industries, including technology, consulting, real estate, and corporate development, focusing on enhancing productivity and fostering authentic relationships among teams. The company, which rebranded from ProsperWorks in 2018, emphasizes an intuitive user experience and instant functionality.

Owkin

Series A in 2019
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Werpx

Grant in 2019
Werpx is a developer of an inventory management platform that addresses the inventory distortion problem by connecting producers, distributors, retailers, and consumers. The platform leverages artificial intelligence to predict consumer demand and ensure that desired products are consistently available on shelves. This innovative approach allows retailers to manage all types of inventory effectively, providing them with valuable insights and optimizing their operations. By enhancing inventory visibility and reducing operational inefficiencies, Werpx enables businesses to lower costs while maintaining quality management in their supply chains.

DroneInch

Pre Seed Round in 2019
DroneInch is a developer of an end-to-end operations management platform designed to streamline drone usage across various industries. The platform enables organizations to remotely plan and operate thousands of autonomous flights while ensuring compliance and safety. It features a mobile app and a web platform that allows businesses to manage multiple users and service providers to oversee multiple clients efficiently. DroneInch’s system employs an AI-powered analytics engine to analyze flight results and facilitate collaboration among global stakeholders through features such as annotation and task flow creation. The platform caters to diverse sectors, including military, government, agriculture, construction, real estate, and public safety, effectively breaking down barriers to widespread drone adoption.

UjuziKilimo

Grant in 2018
UjuziKilimo is a data-driven agronomy services company that leverages innovative data acquisition technologies to collect and analyze farm data. By utilizing data science and machine learning, UjuziKilimo offers actionable agronomic insights to farmers and provides business intelligence and predictive analytics to agricultural service providers and businesses. The company operates a fully integrated data platform, powered by extensive datasets, that enables farmers to enhance their crop productivity. Additionally, UjuziKilimo's tools facilitate knowledge sharing among agricultural stakeholders, allowing them to make informed decisions and develop targeted services through mobile technology.

Vetsark

Grant in 2018
Vetsark is a company that specializes in enhancing productivity and profitability for agribusinesses by facilitating their digital transformation. It develops practice management software designed to streamline business operations and assign tasks effectively. The platform provides real-time business analytics and predictive insights, allowing veterinarians to assess productivity and make informed decisions. Additionally, Vetsark utilizes disease report data to predict, prevent, and manage outbreaks, benefiting livestock farmers, veterinarians, and public health efforts. Through its innovative solutions, Vetsark aims to empower agribusinesses to optimize their operations and increase their income.

CyberGRX

Series C in 2018
CyberGRX is a cybersecurity company based in Denver, Colorado, that specializes in third-party cyber risk management. The company offers a comprehensive platform designed to help organizations identify, assess, mitigate, and monitor their cyber risk exposure across their entire partner ecosystem. By leveraging automation and advanced analytics, CyberGRX enables enterprises to effectively manage and monitor risks associated with their vendors, partners, and customers. The platform provides a cost-effective and scalable solution, allowing organizations to gain complete visibility into their risk portfolio while facilitating real-time decision-making and predictive capabilities.

Machinify

Series A in 2018
Machinify, Inc. is a company that operates a data-to-cash platform aimed at optimizing enterprise operations through artificial intelligence. Founded in 2016 and based in Palo Alto, California, Machinify leverages AI technology to help businesses effectively process their data and uncover hidden profits through automated decision-making. Its offerings include AI Cloud, which manages semi-structured and unstructured real-time data; AI Studio, which facilitates the automated building and testing of AI models through a user-friendly interface; and AI Runtime, which generates the necessary infrastructure for real-time or batch predictions. By automating data collection, transformation, and product deployment, Machinify enables domain experts to transform raw data into smart, automated decisions, ultimately reducing the time required to develop and deploy AI-driven solutions across various sectors, including healthcare.

Viz

Series A in 2018
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Owkin

Series A in 2018
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Le Tote

Series C in 2017
Le Tote, Inc. is an online platform that offers women's apparel and accessories for rent in the United States. Founded in 2012 and headquartered in San Francisco, California, the company provides a wide range of clothing items, including dresses, tops, skirts, pants, and various accessories such as jewelry and handbags. Le Tote employs a data-driven approach to retail, utilizing algorithms and a proprietary style and personalization engine to enhance the shopping experience for its customers. The service aims to replicate the offline behavior of swapping and sharing clothes, facilitating a convenient fashion rental experience through its online portal. However, on August 2, 2020, Le Tote, Inc. and its affiliates filed for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Virginia.

Copper

Series C in 2017
Copper, Inc. is a provider of web-based customer relationship management (CRM) software specifically designed for Google applications, integrating seamlessly with G Suite. Founded in 2011 and headquartered in San Francisco, the company offers a platform that captures data automatically, enabling real-time tracking of sales opportunities and deals. Users can customize their CRM experience with features such as sales forecasting reports, custom fields, and pipeline filters. The software allows for mobile management of sales pipelines, call logging, automated task reminders, and push notifications for new records. Copper serves various industries, including technology, consulting, real estate, and corporate development, focusing on enhancing productivity and fostering authentic relationships among teams. The company, which rebranded from ProsperWorks in 2018, emphasizes an intuitive user experience and instant functionality.

CyberGRX

Series B in 2017
CyberGRX is a cybersecurity company based in Denver, Colorado, that specializes in third-party cyber risk management. The company offers a comprehensive platform designed to help organizations identify, assess, mitigate, and monitor their cyber risk exposure across their entire partner ecosystem. By leveraging automation and advanced analytics, CyberGRX enables enterprises to effectively manage and monitor risks associated with their vendors, partners, and customers. The platform provides a cost-effective and scalable solution, allowing organizations to gain complete visibility into their risk portfolio while facilitating real-time decision-making and predictive capabilities.

Kaggle

Acquisition in 2017
Kaggle Inc. is a prominent platform that facilitates data prediction competitions, allowing organizations to submit their datasets for analysis by a global community of data scientists. Established in 2010 and headquartered in San Francisco, Kaggle serves a diverse range of sectors, including pharmaceuticals, financial services, energy, information technology, and retail. The platform not only hosts competitions but also provides access to datasets, models, and coding resources, enabling users to collaboratively execute and refine their data science projects. Additionally, Kaggle Prospect, one of its offerings, assists companies and government entities in transforming raw data into actionable insights. As a subsidiary of Google, Kaggle continues to foster innovation in data science, positioning itself as a vital resource for professionals seeking to address complex challenges across various industries.

Clear Labs

Series B in 2016
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Urban Engines

Acquisition in 2016
Urban Engines, Inc. is a technology company focused on enhancing urban mobility through advanced data analytics and software solutions. Founded in 2011 and based in Los Altos, California, the company leverages big data from various transportation sources, including transit systems and delivery vehicles, to provide insights that alleviate congestion and improve commuting experiences. Its cloud-based platform facilitates better utilization of existing infrastructure and supports city planning and operations. Additionally, Urban Engines offers a mobile application that provides commuters with city-level insights and optimized routing options, enabling more efficient travel. As of 2016, Urban Engines operates as a subsidiary of Google, enhancing its capabilities in the field of urban transportation.

ClearStory Data

Venture Round in 2016
ClearStory Data Inc. is a provider of data analytics solutions aimed at enhancing business intelligence across various industries, including consumer packaged goods, healthcare, and financial services. Founded in 2011 and headquartered in Menlo Park, California, with an additional office in Chicago, the company specializes in enabling users to easily discover and analyze data from diverse sources, such as relational databases, Hadoop, and third-party data providers. Its platform modernizes data analysis by automating complex tasks like data harmonization and facilitating interactive analysis, allowing organizations to combine corporate and external data for timely insights. This capability empowers business users to make informed decisions quickly, fostering collaboration among distributed teams. ClearStory Data operates as a subsidiary of Alteryx, Inc. as of April 2019.

CyberGRX

Series A in 2016
CyberGRX is a cybersecurity company based in Denver, Colorado, that specializes in third-party cyber risk management. The company offers a comprehensive platform designed to help organizations identify, assess, mitigate, and monitor their cyber risk exposure across their entire partner ecosystem. By leveraging automation and advanced analytics, CyberGRX enables enterprises to effectively manage and monitor risks associated with their vendors, partners, and customers. The platform provides a cost-effective and scalable solution, allowing organizations to gain complete visibility into their risk portfolio while facilitating real-time decision-making and predictive capabilities.

HEAVY.AI

Series A in 2016
HEAVY.AI develops a big data analytics and visualization platform that helps businesses and government entities uncover valuable opportunities and risks within extensive location and time data. Its technology leverages the capabilities of modern GPU and CPU hardware to facilitate high-speed analytics and visualization. The platform features a structured query language-compliant database and an advanced visual analytics engine, allowing users to analyze and visualize large datasets efficiently. Clients from various sectors, including government, telecommunications, energy, utilities, and higher education, utilize HEAVY.AI's solutions to enhance decision-making processes and gain insights from multi-billion record datasets.

Percolata

Venture Round in 2016
Percolata is a Palo Alto-based startup that provides an integrated hardware and software solution designed to assist retailers in predicting in-store customer traffic. Utilizing video, audio, and mobile fingerprinting technologies, the platform employs artificial intelligence and predictive analytics to forecast sales and foot traffic hourly at each location. This capability enables retailers to optimize staffing levels, ensuring that employees are available when customers require assistance, while also reducing the costs associated with over- and understaffing. Percolata's innovative approach has the potential to enhance sales performance by up to 30%, making it a valuable tool for retail operations and marketing strategies. The company has garnered support from prominent investors including Andreessen Horowitz, Menlo Ventures, Foundation Capital, and Google Ventures.

ClearStory Data

Venture Round in 2016
ClearStory Data Inc. is a provider of data analytics solutions aimed at enhancing business intelligence across various industries, including consumer packaged goods, healthcare, and financial services. Founded in 2011 and headquartered in Menlo Park, California, with an additional office in Chicago, the company specializes in enabling users to easily discover and analyze data from diverse sources, such as relational databases, Hadoop, and third-party data providers. Its platform modernizes data analysis by automating complex tasks like data harmonization and facilitating interactive analysis, allowing organizations to combine corporate and external data for timely insights. This capability empowers business users to make informed decisions quickly, fostering collaboration among distributed teams. ClearStory Data operates as a subsidiary of Alteryx, Inc. as of April 2019.

Oration

Series A in 2015
Oration is a provider of a prescription management platform aimed at addressing inefficiencies in the American healthcare system. The company offers predictive analytics tools that enhance the prescription purchasing experience, allowing consumers to make informed decisions based on cost and personal preferences. In the past year, Oration has analyzed over one billion dollars in healthcare transactions, partnering with some of the largest companies in the industry. By focusing on meaningful and complex problems, Oration seeks to empower consumers to save money that would otherwise be lost in the healthcare system, ultimately striving to create a more effective and transparent healthcare purchasing process.

PatientPing

Series A in 2015
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

23andMe

Series E in 2015
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

DFKI

Venture Round in 2015
The German Research Center for Artificial Intelligence (DFKI) GmbH was founded in 1988 as a Public-Private Partnership (PPP). It maintains offices in Kaiserslautern, Saarbrücken, Bremen and a project office in Berlin. DFKI is in the field of innovative software technology based on artificial intelligence techniques, the leading economic research center in Germany. In fifteen research areas and research groups, eight competence centers and six Living Labs product features, prototypes and patentable solutions in the field of information and communication technology will be developed starting from application-oriented basic research. Funding is provided through tendering of public funding authorities such as the European Union, the Federal Ministry of Education and Research (BMBF), the Federal Ministry of Economics and Technology (BMWi), the federal states and the German Research Foundation (DFG) as well as by development contracts from industry. The progress of publicly funded projects will be reviewed twice a year by an international expert panel (Scientific Advisory Board). As part of the five-yearly evaluation by the BMBF, DFKI in 2010 was again a very positive rating. In addition to the federal states of Rhineland-Palatinate, Saarland and Bremen numerous well-known German and foreign high-tech companies are represented in the DFKI Supervisory Board. The successful DFKI model of a non-profit public-private partnership is considered both nationally and internationally as a pioneering structure in the field of cutting-edge research. DFKI is involved in numerous committees for science and technology in Germany and enjoys high reputation far beyond Germany in the training of young scientists. Currently 457 highly qualified scientists and 371 student employees from more than 60 nations to 180 research projects. DFKI serves as a career springboard for young scientists in leadership positions in industry or in self-employment through spin-off companies. More than 60 employees were appointed over the years as professors on chairs at universities and colleges in Germany and abroad.

Yieldify

Series A in 2015
Yieldify Ltd. is a London-based company that operates a multi-channel abandonment analytics platform aimed at converting website visitors into customers. Founded in 2013, Yieldify provides an eCommerce solution that enables online brands to enhance user experiences across various devices. The platform allows users to implement on-site targeting and deploy data-driven email campaigns to recover abandoned visitors. Key features include detailed dashboards for user and campaign analysis, segmentation based on abandonment indicators, and various on-site solutions such as conversion overlays and product recommendations. Yieldify's technology is utilized by over 500 brands across more than 1,000 websites globally, serving diverse sectors including finance, retail, and travel. With additional offices in Berlin and New York, the company has grown rapidly, employing over 170 staff members and securing significant funding from notable investors.

Metabiota

Series A in 2015
Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Clarifai

Series A in 2015
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.

Percolata

Seed Round in 2015
Percolata is a Palo Alto-based startup that provides an integrated hardware and software solution designed to assist retailers in predicting in-store customer traffic. Utilizing video, audio, and mobile fingerprinting technologies, the platform employs artificial intelligence and predictive analytics to forecast sales and foot traffic hourly at each location. This capability enables retailers to optimize staffing levels, ensuring that employees are available when customers require assistance, while also reducing the costs associated with over- and understaffing. Percolata's innovative approach has the potential to enhance sales performance by up to 30%, making it a valuable tool for retail operations and marketing strategies. The company has garnered support from prominent investors including Andreessen Horowitz, Menlo Ventures, Foundation Capital, and Google Ventures.

Adelphic

Series B in 2014
Adelphic, Inc. is a company that specializes in a programmatic advertising platform designed to connect brands with audiences across multiple channels. Established in 2011 and based in Waltham, Massachusetts, Adelphic offers a user-friendly campaign management portal that enables non-technical users to plan, create, launch, and optimize their advertising campaigns. Its platform features an Audience Cube tool, which captures large volumes of data to create custom audience segments and insights, and includes predictive performance engine solutions. The technology is fully real-time bidding (RTB) enabled, allowing access to a wide range of inventory providers, thus facilitating meaningful consumer engagements across various devices and formats. Adelphic primarily serves agencies, brands, and large media buyers, and has been operating as a subsidiary of Viant Technology Inc. since early 2017.

HEAVY.AI

Seed Round in 2014
HEAVY.AI develops a big data analytics and visualization platform that helps businesses and government entities uncover valuable opportunities and risks within extensive location and time data. Its technology leverages the capabilities of modern GPU and CPU hardware to facilitate high-speed analytics and visualization. The platform features a structured query language-compliant database and an advanced visual analytics engine, allowing users to analyze and visualize large datasets efficiently. Clients from various sectors, including government, telecommunications, energy, utilities, and higher education, utilize HEAVY.AI's solutions to enhance decision-making processes and gain insights from multi-billion record datasets.

Tala

Seed Round in 2014
Tala is a global financial technology company focused on delivering accessible financial services to underserved populations in emerging markets, including Kenya, the Philippines, Mexico, and India. The company operates a mobile application that provides users with instant access to a range of financial services, such as credit, payments, savings, and transfers, effectively integrating digital and cash economies. Tala employs advanced data science and machine learning techniques to evaluate creditworthiness in real-time, allowing individuals without formal credit histories to receive personalized credit lines. This innovative approach helps bridge the financial inclusion gap for those in need of essential financial resources.

Skycatch

Venture Round in 2014
Skycatch, Inc. is a technology company based in San Francisco, California, that specializes in aerial data capture and analytics, primarily for the construction and mining industries. The company designs and produces the Evolution3 drone, which enables real-time data capture and 3D rendering. Skycatch also offers a proprietary app called Commander for drone operation, along with Dashboard software that analyzes collected data and facilitates team collaboration. Their platform combines advanced hardware, software, and artificial intelligence to provide clients with high-precision data quickly and efficiently. Founded in 2013, Skycatch focuses on indexing and extracting critical information from the physical world, helping enterprises visualize their environments with accuracy and ease.

Stackdriver

Acquisition in 2014
Stackdriver is a management platform that delivers a straightforward monitoring service for cloud-powered applications, enabling DevOps teams to focus more on development and less on operations. Established in 2012 and acquired by Google in 2014, Stackdriver aids cloud-based companies in identifying and resolving performance issues before they affect customers. Its Intelligent Monitoring features include Rapid Stack Discovery, which quickly maps key system relationships, and Stack Scanner, an analytics engine that detects performance anomalies and predicts capacity constraints. Additionally, Elastic Monitoring allows for the oversight of dynamic resources without constant manual updates, while AWS Insights correlates AWS events with performance metrics to highlight optimization opportunities. Numerous innovative companies, such as Smugmug and 99designs, rely on Stackdriver for reliable system and infrastructure monitoring.

Urban Engines

Seed Round in 2014
Urban Engines, Inc. is a technology company focused on enhancing urban mobility through advanced data analytics and software solutions. Founded in 2011 and based in Los Altos, California, the company leverages big data from various transportation sources, including transit systems and delivery vehicles, to provide insights that alleviate congestion and improve commuting experiences. Its cloud-based platform facilitates better utilization of existing infrastructure and supports city planning and operations. Additionally, Urban Engines offers a mobile application that provides commuters with city-level insights and optimized routing options, enabling more efficient travel. As of 2016, Urban Engines operates as a subsidiary of Google, enhancing its capabilities in the field of urban transportation.

ClearStory Data

Series B in 2014
ClearStory Data Inc. is a provider of data analytics solutions aimed at enhancing business intelligence across various industries, including consumer packaged goods, healthcare, and financial services. Founded in 2011 and headquartered in Menlo Park, California, with an additional office in Chicago, the company specializes in enabling users to easily discover and analyze data from diverse sources, such as relational databases, Hadoop, and third-party data providers. Its platform modernizes data analysis by automating complex tasks like data harmonization and facilitating interactive analysis, allowing organizations to combine corporate and external data for timely insights. This capability empowers business users to make informed decisions quickly, fostering collaboration among distributed teams. ClearStory Data operates as a subsidiary of Alteryx, Inc. as of April 2019.

Metabiota

Seed Round in 2014
Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Cloudera

Series F in 2014
Cloudera, Inc. is a provider of data analytics and management solutions, operating primarily in the United States, Europe, and Asia. The company offers a comprehensive suite of products through its Subscription and Services segments. Its flagship Cloudera Enterprise Data Hub enables organizations to perform various analytics on a governed and secure data set across public and private clouds or data centers. Cloudera also provides a hybrid cloud solution known as Cloudera Data Warehouse for self-service analytics, along with tools like Cloudera Data Science and Engineering for big data processing and Cloudera Operational DB for real-time analytics. Additional offerings include the Hortonworks Data Platform, Cloudera DataFlow for data collection and analysis, and Cloudera SDX for security and governance. Cloudera supports its clients—corporate enterprises and public sector organizations—through software subscriptions and professional services that include consultation, training, and machine learning expertise. Founded in 2008 and headquartered in Palo Alto, California, Cloudera aims to transform complex data into actionable insights while ensuring efficiency and security.

DataFox

Seed Round in 2014
DataFox is a company intelligence platform based in San Francisco that assists sales, marketing, and investment teams in identifying and prioritizing target companies to enhance opportunity sourcing. The platform combines AI-generated insights with verification from a team of over 100 human analysts, delivering comprehensive company data, growth signals, and account scoring. By employing data science and machine learning, DataFox creates proprietary datasets and integrates key leading indicators to rank and score the fastest-growing private companies. The platform is utilized by a diverse range of organizations, from high-growth startups to Fortune 500 companies, including notable names in various industries.

Industrial Pereception

Acquisition in 2013
Industrial Pereception is home to some of the world’s foremost authorities and pioneers in machine vision and artificial intelligence.

DataFox

Seed Round in 2013
DataFox is a company intelligence platform based in San Francisco that assists sales, marketing, and investment teams in identifying and prioritizing target companies to enhance opportunity sourcing. The platform combines AI-generated insights with verification from a team of over 100 human analysts, delivering comprehensive company data, growth signals, and account scoring. By employing data science and machine learning, DataFox creates proprietary datasets and integrates key leading indicators to rank and score the fastest-growing private companies. The platform is utilized by a diverse range of organizations, from high-growth startups to Fortune 500 companies, including notable names in various industries.

Percolata

Convertible Note in 2013
Percolata is a Palo Alto-based startup that provides an integrated hardware and software solution designed to assist retailers in predicting in-store customer traffic. Utilizing video, audio, and mobile fingerprinting technologies, the platform employs artificial intelligence and predictive analytics to forecast sales and foot traffic hourly at each location. This capability enables retailers to optimize staffing levels, ensuring that employees are available when customers require assistance, while also reducing the costs associated with over- and understaffing. Percolata's innovative approach has the potential to enhance sales performance by up to 30%, making it a valuable tool for retail operations and marketing strategies. The company has garnered support from prominent investors including Andreessen Horowitz, Menlo Ventures, Foundation Capital, and Google Ventures.

Weotta

Venture Round in 2013
Weotta is a technology company that specializes in transforming unstructured location and event data into meaningful, contextually relevant insights. By utilizing machine learning and advanced search technology, Weotta enables users to discover local eateries, bars, movies, and events tailored to specific preferences, such as romantic dining or post-game activities. The company's deep ontology allows for nuanced inquiries, enhancing the user experience when seeking recommendations. Weotta showcased its capabilities with the WeottaMakePlans itinerary generator and recently launched WeottaGo, a mobile app designed to help users quickly and enjoyably discover activities nearby. The company has garnered support from leading investors and advisors in the fields of data, local discovery, and search.

Skycatch

Series A in 2013
Skycatch, Inc. is a technology company based in San Francisco, California, that specializes in aerial data capture and analytics, primarily for the construction and mining industries. The company designs and produces the Evolution3 drone, which enables real-time data capture and 3D rendering. Skycatch also offers a proprietary app called Commander for drone operation, along with Dashboard software that analyzes collected data and facilitates team collaboration. Their platform combines advanced hardware, software, and artificial intelligence to provide clients with high-precision data quickly and efficiently. Founded in 2013, Skycatch focuses on indexing and extracting critical information from the physical world, helping enterprises visualize their environments with accuracy and ease.

Optimizely

Series A in 2013
Optimizely, Inc. is a company that operates a website optimization platform designed for A/B testing, multivariate testing, and website personalization, catering to both technical and non-technical users. Founded in 2009 and headquartered in San Francisco, California, it also has offices in Amsterdam, Sydney, and Austin. The platform allows organizations to conduct experiments that facilitate data-driven decision-making and is available in multiple languages, making it accessible to a global audience. Optimizely's offerings include web content management, digital experience software, and integrated capabilities for content, commerce, multi-channel marketing, and predictive analytics. The company serves a diverse clientele, including agencies, developers, e-commerce businesses, enterprises, publishers, and small businesses primarily in the United States, Germany, the United Kingdom, and Spain. Optimizely, formerly known as Spreadly, operates as a subsidiary of EPiServer AB.

Osito

Seed Round in 2013
Osito (formerly Sherpa) is a predictive intelligence iOS app and platform that gets you the information you need so you can stay one step ahead every day. By combining the power of location data with updates from your calendar, email and daily routine, Osito manages the details of everything from work travel to your weekly meetings and commute. Unlike other applications, services or even personal assistants out there, Osito is proactive, not reactive – and location, not calendar based. It learns what you need to know based on the information you provide, including your location as well as your day-to-day routine – making every day just a little easier. Osito was part of **[AngelPad](http://angelpad.org) #4** in 2012.

Periscope Data

Seed Round in 2012
Periscope Data Inc. is a data analytics and visualization platform founded in 2012 and headquartered in San Francisco, California. The company specializes in providing powerful analytics tools that allow users to ingest, store, analyze, visualize, and report on data from a single platform. Periscope Data's technology integrates directly with databases, enabling users to conduct analyses, create dashboards, and share insights without the need for complex programming or upfront modeling. The platform is designed for both data professionals and business users, facilitating quick access to insights that support data-driven decision-making. Trusted by over 1,000 customers, including major companies such as Adobe and EY, Periscope Data has demonstrated strong customer retention and engagement, with users reportedly spending significant time utilizing the platform. In May 2019, Periscope Data became a subsidiary of Sisense Inc., further enhancing its capabilities in the analytics space.

23andMe

Series D in 2012
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

ClearStory Data

Series A in 2012
ClearStory Data Inc. is a provider of data analytics solutions aimed at enhancing business intelligence across various industries, including consumer packaged goods, healthcare, and financial services. Founded in 2011 and headquartered in Menlo Park, California, with an additional office in Chicago, the company specializes in enabling users to easily discover and analyze data from diverse sources, such as relational databases, Hadoop, and third-party data providers. Its platform modernizes data analysis by automating complex tasks like data harmonization and facilitating interactive analysis, allowing organizations to combine corporate and external data for timely insights. This capability empowers business users to make informed decisions quickly, fostering collaboration among distributed teams. ClearStory Data operates as a subsidiary of Alteryx, Inc. as of April 2019.

Adelphic

Series A in 2012
Adelphic, Inc. is a company that specializes in a programmatic advertising platform designed to connect brands with audiences across multiple channels. Established in 2011 and based in Waltham, Massachusetts, Adelphic offers a user-friendly campaign management portal that enables non-technical users to plan, create, launch, and optimize their advertising campaigns. Its platform features an Audience Cube tool, which captures large volumes of data to create custom audience segments and insights, and includes predictive performance engine solutions. The technology is fully real-time bidding (RTB) enabled, allowing access to a wide range of inventory providers, thus facilitating meaningful consumer engagements across various devices and formats. Adelphic primarily serves agencies, brands, and large media buyers, and has been operating as a subsidiary of Viant Technology Inc. since early 2017.

Predilytics

Series A in 2012
Predilytics, Inc. is a healthcare information technology company that specializes in providing analytical solutions to health plans, providers, and other entities involved in risk management. Founded in 2011 and headquartered in Burlington, Massachusetts, the company utilizes advanced machine-learning tools to analyze both structured and unstructured data, along with external data sources, to generate actionable insights. Its offerings include Consumer Acquisition and Retention solutions that help organizations understand consumer behavior to enhance product design and member retention. Additionally, Predilytics provides Care Directions solutions to identify high-risk members who are most likely to benefit from care management, a Risk Adjustment solution aimed at optimizing risk adjustment activities for better reimbursement and care quality, and Quality Insight solutions to identify quality improvement opportunities. As of 2015, Predilytics operates as a subsidiary of Welltok, Inc.

ClearStory Data

Venture Round in 2012
ClearStory Data Inc. is a provider of data analytics solutions aimed at enhancing business intelligence across various industries, including consumer packaged goods, healthcare, and financial services. Founded in 2011 and headquartered in Menlo Park, California, with an additional office in Chicago, the company specializes in enabling users to easily discover and analyze data from diverse sources, such as relational databases, Hadoop, and third-party data providers. Its platform modernizes data analysis by automating complex tasks like data harmonization and facilitating interactive analysis, allowing organizations to combine corporate and external data for timely insights. This capability empowers business users to make informed decisions quickly, fostering collaboration among distributed teams. ClearStory Data operates as a subsidiary of Alteryx, Inc. as of April 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.